Aurora Cannabis Announces Fiscal 2026 Second Quarter Results

• 
  Expands YoY Global Medical Cannabis Net Revenue
  
  
  
  ¹ by 15% to Record $70.5 million
  
• 
  Increases International Medical Cannabis Net Revenue
  
  
  
  ¹ by 22% to Record $42.7 million, with leadership positions across key markets
  
• 
  Delivers Adjusted EBITDA¹ growth of 52%, reaching $15.4 million 
  
• 
  Maintains Strong Balance Sheet with $141.9 million of Cash and Debt-Free Cannabis Business²
  

NASDAQ | TSX: ACB

EDMONTON, AB, Nov. 5, 2025 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2026 period ending September 30, 2025.

“Aurora’s quarterly performance…